regulatory

News

FDA elevates chief scientist Bumpus to the number two role

FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year.

News

UK “keeping up momentum” on clinical trials review

Lord James O’Shaughnessy has welcomed the UK government’s official response to his review of commercial clinical trials, saying there have been a number of positive develo

News

ABPI says UK clinical trials sector ‘improving’

There are glimmers of a recovery in the UK’s clinical research sector, with an uptick in the number of new studies being started, according to a new report.

News

FDA’s Janet Woodcock will step down early next year

Janet Woodcock will bring a career at the FDA spanning almost four decades to a close next year, retiring from her current role as principal deputy commissioner of the reg

News

France reported to be probing Sanofi over Dupixent launch

France’s financial prosecutor has reportedly launched an investigation into Sanofi’s “financial communication” surrounding the launch of its biggest-selling drug Dupixent.

News

EFPIA warns EU reforms will hamstring pharma R&D

A trade organisation representing European pharmaceutical companies warned today that the European Commission’s proposed reforms to pharma legislation could result in the

FDA elevates chief scientist Bumpus to the number two role

UK “keeping up momentum” on clinical trials review

ABPI says UK clinical trials sector ‘improving’

FDA’s Janet Woodcock will step down early next year

France reported to be probing Sanofi over Dupixent launch

EFPIA warns EU reforms will hamstring pharma R&D

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

regulatory

Editor's Picks